CAD hijacks STING to impair antitumor immunity and radiotherapy efficacy of colorectal cancer
2025 · Cell Death and Disease · 3 citations
https://doi.org/10.1038/s41419-025-07964-8
Tianjin Medical University Cancer Institute and Hospital(CN)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
3
Papers
31
Citations
2
h-index
1
i10-index
Zeyuan Cheng is an academic researcher from Tianjin Medical University Cancer Institute and Hospital. The author has contributed to research in topics: Cancer-related molecular mechanisms research & Chronic Myeloid Leukemia Treatments & Ferroptosis and cancer prognosis. The author has an h-index of 2, co-authored 3 publications.
ORCID: 0009-0004-2769-0336Click to start Chat